Key multiplicity issues in clinical drug development
Author:
Affiliation:
1. Quintiles, Inc.; Durham; NC; U.S.A.
2. Boston University; Boston; MA; U.S.A.
3. Office of Biostatistics, OTS, CDER; U.S. Food and Drug Administration; Silver Spring; MD; U.S.A.
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference62 articles.
1. Committee for Proprietary Medicinal Products Points to consider on multiplicity issues in clinical trials 2002
2. Multiple Comparison Procedures
3. Multiple Testing Problems in Pharmaceutical Statistics
4. Multiple Testing Problems in Pharmaceutical Statistics
5. Strategies for dealing with multiple treatment comparisons in confirmatory clinical trials;D'Agostino;Drug Information Journal,1993
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence;Journal of Cardiovascular Development and Disease;2024-06-21
2. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review;BMC Medical Research Methodology;2024-05-07
3. A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart;Statistics in Medicine;2024-04-02
4. Bayesian and Frequentist Approaches to Rescuing Disrupted Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions;Statistics in Biopharmaceutical Research;2024-03-19
5. Drugdevelopr: Planning of Phase Ii/Iii Drug Development Programs with Optimal Sample Size Allocation and Go/No-Go Decision Rules in R;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3